Which hedge funds own EDIT? EDITAS MEDICINE INC, Q2 2026 13F holders
30 tracked hedge funds disclosed a position in EDIT (EDITAS MEDICINE INC) in their Q2 2026 13F filings, worth $191.7m in total. The largest holder by portfolio weight is GordonMD Global Investments LP at 4.9% of its book. 19 opened a new position this quarter: GordonMD Global Investments LP, Commodore Capital LP, ADAR1 Capital Management, LLC, Seven Fleet Capital Management LP. 1 exited: Quantbot Technologies LP.
- 30
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 19
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 1
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $145m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $42
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $192m
- Combined value Sum of the holders' reported positions in the security.
- 2.4%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Quantbot Technologies LP | 0.0% | $42 |
Ownership over time
Who discovered EDIT first? Beta
| Deerfield Management Company, L.P. | Q1 2016 | +1.0 pts |
| Casdin Capital, LLC | Q1 2016 | +0.3 pts |
| Sabby Management, LLC | Q1 2017 | 0.0 pts |
| Tri Locum Partners LP | Q2 2023 | −0.1 pts |
| Valiant Capital Management, L.P. | Q3 2018 | −0.3 pts |
| EcoR1 Capital, LLC | Q4 2016 | −0.4 pts |
| Deep Track Capital, LP | Q2 2023 | −0.6 pts |
| Wildcat Capital Management, LLC high conviction | Q1 2016 | −2.3 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.